Vitrolife AB is an international biotechnology corporation. The Company develops, produces, and markets products for creating, prolonging, and improving life. Vitrolife focuses on fertility treatments, cell therapy and tissue engineering, organ transplantation systems, and products base on hyaluronic acid. The Company researches and manufactures in Europe and the United States.
Kungsbacka, 434 37